Product Description
Acetylcholine Chloride is the chloride salt form of acetylcholine, a synthetic, quaternary amino alcohol with cholinergic properties. Acetylcholine chloride mimics the parasympathomimetic effect of the endogenous compound acetylcholine. Administered as an ophthalmic solution, this drug stimulates the cholinoceptors in the sphincter muscle of the iris, causing the pupil to constrict. (NCI05)
Mechanisms of Action: AChR Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intramuscular,Transdermal,Oral,Topical,Intraocular,Intravenous
FDA Designation: None *
Approval Status: Approved
Approved Countries: Australia | Canada | Chile | Colombia | Finland | France | Germany | Greece | Ireland | Italy | Japan | Jordan | Korea | Lebanon | Luxembourg | Malta | Mexico | Netherlands | New Zealand | Peru | Portugal | Singapore | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | United Kingdom | United States | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|